Intercellular adhesion molecules (ICAMs) 2 and 3 are frequently expressed in B cell chronic lymphocytic leukemia

Leukemia

Volumn 10, Issue 5, 1996, Pages 907-908

  Molica, S ^a   Dattilo, A ^a   Mannella, A ^a   Levato, D ^a  

^a Presidio Ospedaliero di Tione di Trento Reparto di Ortopedia e Traumatologia Via Ospedale   (Italy)

Author keywords

B CLL; ICAM 1; ICAM 3

Indexed keywords

CD5 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 2; INTERCELLULAR ADHESION MOLECULE 3; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0030049817     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Mariin SD, Springer TA. Purified intercellular adhesion molecule1 (ICAM-1) is a ligand for lymphocyte function-associated antigen-1 (LFA-1). Cell 1987; 51: 813-817.
2. Staunton DE, Dustin ML, Springer TA. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature 1989; 339: 61-64.
3. Nortamo P et al. The expression of human intercellular adhesion molecule-2 is refractory to inflammatory cytokynes. Eur J Immunol 1991; 21: 2629-2632.
4. de Fougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of ICAM-2 and evidence for a third counter receptor of LFA-1. J Exp Med 1991; 174: 253-267.
5. de Fougerolles AR, Springer TA. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J Exp Med 1992; 175: 185-190.
6. Pinto A, Gattei V, Soligo D, Parravicini C, Del Vecchio L. New molecules burst at the leukocyte surface. A comprehensive review based on the 5th International Workshop on Leukocyte Differentiation Antigens, Boston, USA, 3-7 November, 1993. Leukemia 1994; 8: 347-358.
7. Maio M et al. Differential expression of CD54/intercellular adhesion molecule 1 in myeloid leukemias and in lymphoproliferative disorders. Blood 1990; 76: 783-790.
8. Christiansen I, Gidlog C, Wallgreen AC, Simonson B, Totterman TH. Serum levels of soluble intercellular adhesion molecule-1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers. Blood 1994; 84: 3010-3016.
9. Molica S, Dattilo A, Mannella A, Levato D, Levato L. Expression on leukemic cells and serum circulating levels of intercellular adhesion molecule-1 (ICAM-1) in B-cell chronic lymphocytic leukemia: implications for prognosis. Leukemia Res 1995; 19: 573-580.
10. Molica S, Dattilo A, Mannella A. ICAM-1 expression in B-cell chronic lymphocytic leukemia. Analysis of results obtained with 11 different CD54-specific monoclonal antibodies. Leukemia 1995; 9: 934-935.
11. Marotta G, Zagonel V, Pinto A. Induction of LFA-1/CD11a and ICAM-1/CD54 adhesion molecules on neoplastic B cells during 'in vivo' treatment of chronic lymphocytic leukemia with interferon alpha-2. Blood 1993; 81: 267-269.
12. Caligaris-Cappio F, Bergui L, Schena M, Chilosi M, Marchisio PC. Cell-cell and cell-matrix adhesion structures may influence the growth pattern of chronic lymphoid malignancies. Leukemia 1989; 3: 167-169.
13. Renkonen R, Paavonen T, Nortamo P, Gahmberg CG. Expression on endothelial adhesion molecules in vivo. Increased endothelial ICAM-2 expression in lymphoid malignancies. Am J Pathol 1992; 10: 763-767.